Roche, GE Project Brings New Spin To Clinical Decision Support
The clinical decision support market is certainly crowded, and what’s more, CDS solutions vary in some important ways.…
Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche received the CE mark for its Elecsys pTau217 blood test, an assay designed to detect Alzheimer’s disease…
Roche’s Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer’s-related amyloid pathology
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access…